Does this AI system or service reach the EU market or people in the EU?
EU AI Act obligations can apply based on market placement, deployment, affected persons, or outputs used in the Union.
Fourteen questions. No credit card. No compliance claim. The purpose is to identify the evidence and obligation pathways worth examining before you spend money.
EU AI Act obligations can apply based on market placement, deployment, affected persons, or outputs used in the Union.
This can indicate a provider role or a need for provider-role analysis.
This can indicate deployer obligations even when another company built the system.
This may create Article 50 transparency questions depending on the system and context.
Synthetic-content marking and disclosure pathways may need to be evaluated.
Certain employment-related uses can fall into high-risk categories depending on the facts.
Certain education-related uses can fall into high-risk categories.
Certain financial or eligibility uses may trigger heightened requirements.
These contexts can materially change the risk and obligation picture.
Biometric use can involve prohibited-practice, high-risk, and transparency questions.
Product-safety integration can affect high-risk timing and conformity pathways.
GPAI providers have a distinct obligations pathway.
Material change can weaken reliance on earlier evidence and trigger revalidation.
Policies and intentions are not the same as contemporaneous evidence that a control actually operated.
This screen does not determine legal compliance, high-risk classification, or conformity status. It identifies issues that may justify evidence mapping, qualified legal analysis, or further review.
TA-14 Exchange Activity
Public activity recorded across the Exchange
—
Visitors
—
Page Views